NHC heads into its May 19 earnings event with shorts cutting positions and options traders sitting far more relaxed than they were a month ago — a setup that looks like a vote of confidence after a blowout Q1 print.
The stock has moved fast. NHC closed at $193.65 on Friday, up 18.4% over the past month. A single-day dip of 2.2% on May 15 stands out, arriving on the same day the company filed an 8-K disclosing a $50.5 million agreement to sell five skilled nursing facilities. But the one-week gain of 2.6% shows that dip has already been absorbed.
The clearest story in positioning is the sharp retreat in short interest. Estimated short interest fell nearly 10% over the past week, from around 772,000 shares to roughly 700,000. SI now represents approximately 4.5% of the float by ORTEX estimates — a meaningful level, but down sharply from the 9% range seen earlier in April using an alternative float calculation. The move is a direct response to the May 7 earnings beat, which sent the stock up 11.5% in a single session and a further 5.4% over the following week. Shorts that built into that event took the loss and covered. Cost to borrow, at 0.55% annualised, has barely moved and signals no stress in the lending market. Availability remains comfortable, well clear of the levels that would indicate squeeze pressure. The short score has also drifted lower through the week, from 48.9 on May 1 down to 46.7 by May 14 — a modest but consistent easing in bearish conviction.
Options are a supporting data point, not an alarm. The put/call ratio is running at 0.22, modestly above its 20-day mean of 0.19 and about one standard deviation above normal — not a defensive panic, more a mild hedge into the next event. The 52-week high on the PCR is 6.4, set during a very different market moment in April; the current reading is near the lower end of recent history. Taken alongside the short retreat, it paints a picture of a market that is positioning cautiously but not aggressively against the stock.
The ownership structure is unusually stable. BlackRock holds 12.2% and recently added to its position. Vanguard sits at 9.0% and the company's own ESOP holds 6.6%. Richard LaRoche, listed among the top holders, added 7,500 shares as of May 7. On the sell side, a cluster of insider sales hit in early March — the CEO, CIO, General Counsel, and multiple senior vice presidents all sold on the same day — but those were at prices around $172, well below current levels. The most recent insider transaction, an SVP sale in late April at $173.63, looks similarly mechanical in nature. The net picture over 90 days is a small net positive in share terms, and the insiders who sold in March have watched the price run significantly above their exit levels.
The earnings track record is worth noting. The May 7 print produced the biggest single-day move in the available history at +11.5%. The prior two events produced gains of 2.0% on the day and around 4.8% over the following week. Only one of the four available data points shows a negative outcome — a 1.1% one-day dip followed by a 4.5% five-day pullback. The pattern is more consistent-positive than volatile, which may partly explain why short sellers have not rebuilt positions aggressively ahead of the May 19 event. NHC also carries a dividend score in the 97th percentile, and while the most recent dividend history in the snapshot is stale, the score suggests the company is still viewed as a reliable income name.
The $50.5 million asset sale announced on May 15 — five skilled nursing facilities sold to NHC/OP — is the next thing to watch. Whether management frames this as balance sheet optimisation, a reallocation toward higher-margin assets, or something else entirely will determine how the May 19 call lands for investors who are now holding the stock near 12-month highs.
See the live data behind this article on ORTEX.
Open NHC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
